Europe — EMA
Myopridin (Pridinol Mesilate)
GNH USA supplies Myopridin (Pridinol mesilate), a muscle relaxant for muscle spasm and skeletal muscle pain. Request a quote for global supply today.
Request sourcing
What is Pridinol Mesilate?
Pridinol mesilate, the active ingredient in Myopridin, is a muscle relaxant presented as a injection for intramuscular use. It treats muscle spasm and skeletal muscle pain in adult patients.
GNH USA supplies Myopridin as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Pridinol Mesilate used for?
Myopridin, a muscle relaxant, is used to manage conditions involving skeletal muscle hyperactivity.
- Muscle spasm: provides relief of involuntary muscle contraction. - Skeletal muscle pain: reduces pain associated with muscle strain. - Muscle cramps: alleviates painful, recurrent cramps.
What are the side effects of Pridinol Mesilate?
Adverse reactions may occur with intramuscular administration of Myopridin.
Common Side Effects: - Drowsiness: feeling of sleepiness. - Dry mouth: reduced salivation. - Nausea: mild stomach upset. - Dizziness: light‑headed sensation.
Serious or Rare Side Effects: - Allergic reaction: rash, itching, swelling, or anaphylaxis. - Hepatic dysfunction: elevated liver enzymes or jaundice. - Cardiac arrhythmia: irregular heartbeat.
What precautions apply to Pridinol Mesilate?
Before using Myopridin, consider the following safety measures. - Renal/hepatic assessment: evaluate liver and kidney function prior to therapy. - CNS depression monitoring: watch for excessive sedation when combined with other depressants. - Elderly caution: start with the lowest effective dose in older adults. - Concomitant drug review: avoid simultaneous use of strong CNS depressants. - Store at ambient temperature: keep in the original pack, protect from moisture and light.
What does Pridinol Mesilate interact with?
Myopridin may interact with other medicines; awareness of these interactions helps prevent adverse outcomes.
Major Interactions (Avoid): - MAO inhibitors: risk of severe hypotension. - CNS depressants (e.g., benzodiazepines, opioids): additive sedation. - Alcohol: increased drowsiness.
Moderate Interactions (Monitor Closely): - Anticholinergic agents: may enhance dry mouth. - Diuretics: possible electrolyte imbalance. - Antihistamines: may increase dizziness.



